OverviewSuggest Edit

ElectroCore is a bioelectric medicine healthcare company, which develops a non-invasive self-administered Vagus Nerve Stimulation (nVNS) therapy for the treatment of multiple conditions in neurology, psychiatry, respiratory, gastroenterology, and headaches. It focuses on primary headaches, such as migraine and cluster and trials in epilepsy, gastric motility disorders, depression, and anxiety. The Company sells its products to patients through healthcare professionals in the United Kingdom, Germany, Italy, Australia, and Canada.

TypePublic
Founded2005
HQBernards, US
Websiteelectrocore.com

Latest Updates

Employees (est.) (Jun 2018)69(+7%)
Share Price (May 2019)$2.7 (-13%)

Key People/Management at ElectroCore

Francis R. Amato

Francis R. Amato

CEO, Chief Executive Officer, electroCore
JP Errico

JP Errico

Founder, Chief Science & Strategy Officer, Chairman, Founder, Principal Investor and Chief Science & Strategy Officer, electroCore
Steve Mendez

Steve Mendez

Founder, Chief Technical Officer
Peter S. Staats

Peter S. Staats

Founder, Chief Medical Officer
Glenn S. Vraniak

Glenn S. Vraniak

CFO
Dan Duhart

Dan Duhart

Chief Commercial Officer
Show more

ElectroCore Office Locations

ElectroCore has offices in Bernards, Yeadon, Parksville, Hamburg and in 1 other location
Bernards, US (HQ)
150 Allen Rd #201, Basking Ridge
Parksville, CA
Rathtrevor Parking Lot 2
Geretsried, DE
Amberger Straße 1-3
Hamburg, DE
214 Weg beim Jäger
Yeadon, GB
Unit 4-7 Gateway Drive
Show all (5)

ElectroCore Financials and Metrics

ElectroCore Revenue

Market capitalization (22-May-2019)

80.0m

Closing stock price (22-May-2019)

2.7
ElectroCore's current market capitalization is $80 m.
Show all financial metrics

ElectroCore Online and Social Media Presence

Embed Graph

ElectroCore News and Updates

ElectroCore Blogs

electroCore to Announce Fourth Quarter and Year Ended December 31, 2018 Financial Results on Wednesday, March 27

Conference Call to be Held at 4:30pm Eastern Time BASKING RIDGE, N.J. , March 18, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that it will report fourth quarter and year ended December 31, 2018 financial results after

electroCore Announces Encouraging Research Supporting Key Areas of Clinical Development for its Non-Invasive Vagus Nerve Stimulator, gammaCore™

Data presented at the 3rd International Brain Stimulation Conference support the use of nVNS for treatment of mild traumatic brain injury and rheumatoid arthritis BASKING RIDGE, N.J. , March 14, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a global commercial-stage bioelectronic

electroCore Appoints Multiple Industry Veterans to Key Management Positions

Dr. Tony Fiorino to serve as Chief Medical Officer and Brian Posner as Chief Financial Officer BASKING RIDGE, N.J. , March 08, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the appointments of Dr.

electroCore Announces Positive Coverage Policies of gammaCore Issued by Highmark

BASKING RIDGE, N.J. , Feb. 26, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that Highmark, one of the nation’s top health insurers and the third largest Blue Cross Blue Shield affiliated company, has determined that

electroCore and HealthyWomen Announce Partnership on Patient Program to Increase Awareness of Non-Drug Migraine Therapies

BASKING RIDGE, N.J. and NEW YORK, Feb. 19, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc . (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced a patient education initiative in partnership with HealthyWomen , the nation’s leading independent, nonprofit health information

electroCore to Present at Noble Capital Markets’ Fifteenth Annual Investor Conference

BASKING RIDGE, N.J. , Jan. 28, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc.  (“electroCore”) (Nasdaq:ECOR), a commercial-stage bioelectronic medicine company, today announced Chief Executive Officer, Frank Amato and Chief Science & Strategy Officer, JP Errico will present at NobleConXV - Noble
Show more

ElectroCore Frequently Asked Questions

  • When was ElectroCore founded?

    ElectroCore was founded in 2005.

  • Who are ElectroCore key executives?

    ElectroCore's key executives are Francis R. Amato, JP Errico and Steve Mendez.

  • How many employees does ElectroCore have?

    ElectroCore has 69 employees.

  • Who are ElectroCore competitors?

    Competitors of ElectroCore include miRagen Therapeutics, FIRE1 and Sonendo.

  • Where is ElectroCore headquarters?

    ElectroCore headquarters is located at 150 Allen Rd #201, Basking Ridge, Bernards.

  • Where are ElectroCore offices?

    ElectroCore has offices in Bernards, Yeadon, Parksville, Hamburg and in 1 other location.

  • How many offices does ElectroCore have?

    ElectroCore has 5 offices.